Pfizer AstraZeneca takeover: Drugs may be a long-term business, but size matters

Science Editor

Science and business sometimes make strange bedfellows and there is perhaps no better example of marital harmony – and strife – than the relationship between scientific research and the drugs industry.

Drug companies are of course designed to make a profit and provide a financial return on their considerable investment in new medicines. It is a long-term strategy that can so easily be torpedoed by short-term business tactics – like the proposed takeover of the British-based AstraZeneca by American giant Pfizer.

Science, meanwhile, is about the steady march of knowledge and the progressive, incremental gains of research and development. It can only thrive in an environment of stability and dedicated investment – or at least this is what you might imagine.

Takeovers are therefore often seen as a threat to science because they represent instability and periods of change. Whenever they have occurred in the pharmaceuticals sector, they have usually involved the merger or closure of research facilities, so why should Pfizer’s “praying-mantis” approach to AstraZeneca be any different?

Sir Richard Sykes, one of Britain’s most experienced drug-industry executives, and a former research scientist himself, is not one of those who thinks that takeovers are necessarily bad. In fact, he believes there has been a lot of “hot air” spoken about the merger between Pfizer and AstraZeneca and the fears that the American giant will close down much of the UK research operation.

“The value in the pharmaceuticals industry is intellectual capital, whether that’s people, or whether it’s drugs. That’s where the value lies. So why would you want to destroy value?” he told The Independent.

“If we create in the UK the right, stable environment to attract companies, and particularly high-tech companies like pharmaceutical companies, and provide them the right environment in which to operate, then why would they not want to invest?”

Sir Richard, who now chairs Imperial College Healthcare NHS Trust, knows more about drug-industry mergers than most. He was head of Glaxo when it merged with Wellcome in 1995 to form GlaxoWellcome – which five years later became GlaxoSmithKline when it merged with SmithKlineBeecham.

Today the company, which is the biggest drugs company in Britain, is known simply as “GSK”, initials that only give a hint at the great names of the former companies in its takeover history.

Sir Richard Sykes, former head of Glaxo (David Sandison) Sir Richard Sykes, former head of Glaxo (David Sandison)
But the Wellcome element still survives now as the non-profit Wellcome Trust, the huge medical research charity which is worth billions and spends hundreds of millions of pounds each year on bioscientific research.

AstraZeneca itself would probably not have existed had it not been for a takeover bid for ICI by Hanson, which resulted in the British chemicals giant jettisoning its pharmaceuticals business in the form of Zeneca. And it was of course an Anglo-Swedish merger that brought Astra and Zeneca together in 1999.

The fact is, Britain “does” drugs rather well. Its pharmaceuticals sector is one of the best in the world, partly for historical reasons to do with the size and spending power of the NHS. Not only did the NHS provide a captive home market for drugs companies, but successive governments actively encouraged research and development here by something called the Pharmaceutical Price Regulation Scheme, which was first introduced in 1957 and was intended to reward companies that carried out their scientific research in the UK.

The great fear is that Pfizer will take the most profitable parts of AstraZeneca and close down the rest. Short-termism is what scientists (and some politicians) worry about most.

“Whatever the outcome of the Pfizer bid for AstraZeneca, it remains vital to the UK economy and to the long term sustainability of life sciences companies that there is strong investment in the research required to deliver new treatments,” said Sir Paul Nurse, the president of the Royal Society and director of the new Francis Crick Institute, where publicly-funded biomedical researchers will work closely with the private sector.

“Sadly, too much of the focus of this debate has been on current share values, tax breaks and the short-term profits that can be made on the deal. This is exactly the sort of ‘get rich quick’ culture that brought the global economy to its knees a few years ago,” Sir Paul said.

“We need to return to a mindset that is about investing in sustainable, long term growth and for the pharmaceutical industry that means investing in the best research, much of which is done here in the UK.”

But no-one can deny that size matters in the drugs industry. The costs of bringing a new drug to market are enormous, and many, many more putative drugs fail to get through the regulatory system than succeed.

“In drug research and development, critical mass is absolutely important. It costs billions now to bring drugs to the market. It’s a 20-year business – minimum,” Sir Richard said.

“This is a good time to attract global pharma companies back into the UK to do their R and D. I see it as a great opportunity,” he said.

“So rather than attacking this [proposed merger] on political grounds, we should be saying we encourage inward investment. I agree it would be good to get some firm commitments from Pfizer, particularly a commitment on the basis that they do agree that this is one of the best places on earth to do their research and development.”

Start your day with The Independent, sign up for daily news emails
News
people

Harry Potter actor suffered 'severe flu-like symptoms' on a flight from London to Orlando

Arts and Entertainment
Legendary Star Wars filmmaker George Lucas
film
News
news
Arts and Entertainment
tv

First full-length look is finally here

PROMOTED VIDEO
ebooks
ebooksA special investigation by Andy McSmith
Arts and Entertainment
Frank Turner performing at 93 Feet East
musicReview: 93 Feet East, London
News
Toronto tops the charts across a range of indexes
news

World cities ranked in terms of safety, food security and 'liveability'

Extras
indybest
Voices
A mother and her child
voices
Voices
The veterans Mark Hayward, Hugh Thompson and Sean Staines (back) with Grayson Perry (front left) and Evgeny Lebedev
charity appealMaverick artist Grayson Perry backs our campaign
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Digital Content Manager

£26000 - £31000 per annum: Recruitment Genius: A Digital Content Manager is re...

Recruitment Genius: Senior .Net Application Developer

£40000 - £60000 per annum: Recruitment Genius: This is a fantastic opportunity...

Recruitment Genius: Office Administrator

£14000 - £17500 per annum: Recruitment Genius: The successful applicant will b...

Recruitment Genius: Continuous Improvement Manager

£41500 per annum: Recruitment Genius: This company is going through a period o...

Day In a Page

Isis hostage crisis: The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power

Isis hostage crisis

The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power, says Robert Fisk
Missing salvage expert who found $50m of sunken treasure before disappearing, tracked down at last

The runaway buccaneers and the ship full of gold

Salvage expert Tommy Thompson found sunken treasure worth millions. Then he vanished... until now
Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

Maverick artist Grayson Perry backs our campaign
Assisted Dying Bill: I want to be able to decide about my own death - I want to have control of my life

Assisted Dying Bill: 'I want control of my life'

This week the Assisted Dying Bill is debated in the Lords. Virginia Ironside, who has already made plans for her own self-deliverance, argues that it's time we allowed people a humane, compassionate death
Move over, kale - cabbage is the new rising star

Cabbage is king again

Sophie Morris banishes thoughts of soggy school dinners and turns over a new leaf
11 best winter skin treats

Give your moisturiser a helping hand: 11 best winter skin treats

Get an extra boost of nourishment from one of these hard-working products
Paul Scholes column: The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him

Paul Scholes column

The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
Frank Warren column: No cigar, but pots of money: here come the Cubans

Frank Warren's Ringside

No cigar, but pots of money: here come the Cubans
Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

Isis stands strong as its numerous enemies fail to find a common plan to defeat it

The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

Virtual reality: Seeing is believing

Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
Homeless Veterans appeal: MP says Coalition ‘not doing enough’

Homeless Veterans appeal

MP says Coalition ‘not doing enough’ to help
Larry David, Steve Coogan and other comedians share stories of depression in new documentary

Comedians share stories of depression

The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
Has The Archers lost the plot with it's spicy storylines?

Has The Archers lost the plot?

A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
English Heritage adds 14 post-war office buildings to its protected lists

14 office buildings added to protected lists

Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

Scientists unearthed the cranial fragments from Manot Cave in West Galilee